Switzerland In Vitro Fertilization Market Size & Outlook
The in vitro fertilization market in Switzerland is expected to reach a projected revenue of US$ 464.6 million by 2033. A compound annual growth rate of 5.07% is expected of Switzerland in vitro fertilization market from 2026 to 2033.
Bayer AG, Cook Medical, Merck KGaA, Ferring, FUJIFILM Holdings Corp, Genea Biomedx, Merck & Co Inc, The Cooper Companies Inc, Thermo Fisher Scientific Inc, Vitrolife AB ADR, Boston Scientific Corp, Nova IVF, Fortis Healthcare, RMA Network, TFP Fertility Group, US Fertility
Other key industry trends
In terms of revenue, Switzerland accounted for 1.1% of the global in vitro fertilization market in 2025.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
In Europe, Germany in vitro fertilization market is projected to lead the regional market in terms of revenue in 2033.
Germany is the fastest growing regional market in Europe and is projected to reach USD 2,608.0 million by 2033.
According to the Federal Statistical Office, the number of children born in Switzerland through the utilization of ART, specifically IVF, increased by 13% in 2021 compared to the previous year. The data indicates that approximately 2,500 children were born as a result of IVF treatments during that period.
In addition, in around 35% of cases, infertility was attributed to the man, while in approximately 27% of cases, the woman was identified as the cause of infertility. In the remaining instances, either both partners had infertility issues or the cause of infertility remained unclear.
Furthermore, Switzerland attracts some medical tourists seeking IVF treatments due to its reputation for high-quality healthcare services. Factors such as the expertise of Swiss fertility specialists and the country's scenic locations contribute to its appeal.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to In Vitro Fertilization Market Outlook will help companies and investors design strategic landscapes.
Frozen Nondonor was the largest segment with a revenue share of 51.74% in 2025.
Horizon Databook has segmented the Switzerland in vitro fertilization market based on fresh nondonor, frozen nondonor, fresh donor, frozen donor covering the revenue growth of each sub-segment from 2021 to 2033.
According to the Federal Statistical Office, the number of children born in Switzerland through the utilization of ART, specifically IVF, increased by 13% in 2021 compared to the previous year. The data indicates that approximately 2,500 children were born as a result of IVF treatments during that period.
In addition, in around 35% of cases, infertility was attributed to the man, while in approximately 27% of cases, the woman was identified as the cause of infertility. In the remaining instances, either both partners had infertility issues or the cause of infertility remained unclear.
Furthermore, Switzerland attracts some medical tourists seeking IVF treatments due to its reputation for high-quality healthcare services. Factors such as the expertise of Swiss fertility specialists and the country's scenic locations contribute to its appeal.
Switzerland In Vitro Fertilization Market Procedure Type Outlook (Revenue, USD Million , 2021-2033)
Fresh Nondonor
Frozen Nondonor
Fresh Donor
Frozen Donor
Switzerland In Vitro Fertilization Market Providers Outlook (Revenue, USD Million , 2021-2033)
Fertility Clinics
Hospitals and Other Settings
Reasons to subscribe to In Vitro Fertilization Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of In Vitro Fertilization Market Outlook databook
Our clientele includes a mix of In Vitro Fertilization Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Switzerland In Vitro Fertilization Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Switzerland In Vitro Fertilization Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Switzerland In Vitro Fertilization Market, 2021-2033 (US$M)